Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Translational Andrology and Urology|November 22, 2021
Assessment of prognosis by established prognosis scores and physicians' judgement in mRCC patients: an analysis of the STAR-TOR registryMartin Boegemann, Peter Jürgen Goebell, Michael Woike, et al.
International Journal of Molecular Sciences|September 13, 2016
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate CancerKatrin Schlack, Laura-Maria Krabbe, Manfred Fobker, et al.
Translational Andrology and Urology|October 28, 2016
Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?Yvonne Klaile, Katrin Schlack, Martin Boegemann, et al.
Cancers|August 7, 2021
Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future PerspectivesKonstantin Egon Seifert, Robert Seifert, Katharina Kessel, et al.
Anticancer Research|November 7, 2018
Sunitinib Treatment Modification in First-Line Metastatic Renal Cell Carcinoma: Analysis of the STAR-TOR RegistryMartin Boegemann, Marcus Hubbe, Despina Thomaidou, et al.
Translational Andrology and Urology|November 22, 2021
ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysisKatrin Schlack, Laura-Maria Krabbe, Kambiz Rahbar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted TherapyRobert Seifert, Katharina Kessel, Martin Boegemann, et al.
World Journal of Urology|June 28, 2018
Molecularly-driven precision medicine for advanced bladder cancerLaura-Maria Krabbe, Vitaly Margulis, Andres Jan Schrader, et al.
Pageof 6